phenserine has been researched along with amyloid beta-peptides in 1 studies
| Studies (phenserine) | Trials (phenserine) | Recent Studies (post-2010) (phenserine) | Studies (amyloid beta-peptides) | Trials (amyloid beta-peptides) | Recent Studies (post-2010) (amyloid beta-peptides) |
|---|---|---|---|---|---|
| 88 | 6 | 39 | 3,257 | 48 | 1,626 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Almkvist, O; Andreasen, N; Kadir, A; Långström, B; Nordberg, A; Wall, A; Zetterberg, H | 1 |
1 trial(s) available for phenserine and amyloid beta-peptides
| Article | Year |
|---|---|
Correlations between Alzheimer's Disease Cerebrospinal Fluid Biomarkers and Cerebral Glucose Metabolism after 12 Months of Phenserine Treatment.
Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Biomarkers; Brain; Cognition; Double-Blind Method; Female; Glucose; Humans; Male; Nootropic Agents; Peptide Fragments; Phosphorylation; Physostigmine; Positron-Emission Tomography; tau Proteins; Time Factors; Treatment Outcome | 2015 |